Imperial College London
Alternate

ProfessorSimonGregson

Faculty of Medicine, School of Public Health

Professor in Demography and Behavioural Science
 
 
 
//

Contact

 

+44 (0)20 7594 3279s.gregson

 
 
//

Location

 

LG27Praed StreetSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Eaton:2017:cid/cix341,
author = {Eaton, JW and Johnson, CC and Gregson, S},
doi = {cid/cix341},
journal = {Clinical Infectious Diseases},
pages = {522--525},
title = {The cost of not re-testing: HIV misdiagnosis in the ART ‘test-and-offer’ era},
url = {http://dx.doi.org/10.1093/cid/cix341},
volume = {65},
year = {2017}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - We compared estimated costs of retesting human immunodeficiency virus (HIV)-positive persons before antiretroviral therapy (ART) initiation to the costs of ART provision to misdiagnosed HIV-negative persons. Savings from averted unnecessary ART costs were greater than retesting costs within 1 year using assumptions representative of HIV testing performance in programmatic settings. Countries should implement re-testing before ART initiation.
AU  - Eaton,JW
AU  - Johnson,CC
AU  - Gregson,S
DO  - cid/cix341
EP  - 525
PY  - 2017///
SN  - 1537-6591
SP  - 522
TI  - The cost of not re-testing: HIV misdiagnosis in the ART ‘test-and-offer’ era
T2  - Clinical Infectious Diseases
UR  - http://dx.doi.org/10.1093/cid/cix341
UR  - http://hdl.handle.net/10044/1/48246
VL  - 65
ER  -
Download